(Q46173172)

20 December 2017

title

Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin (English)

1 reference

20 December 2017

methicillin-resistant Staphylococcus aureus

main subject

0 references

vancomycin

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

Frank X Placencia

1

1 reference

20 December 2017

Lingkun Kong

series ordinal

2

1 reference

20 December 2017

Leonard E Weisman

series ordinal

3

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

20 December 2017

published in

Pediatric Research

1 reference

20 December 2017

volume

65

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

420-424

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1203/pdr.0b013e3181994a53

exact match

0 references

cites work

Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Serious bacterial infections in newborn infants in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Outbreak of invasive disease caused by methicillin-resistant Staphylococcus aureus in neonates and prevalence in the neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Lysostaphin in treatment of neonatal Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Systemic lysostaphin in man--apparent antimicrobial activity in a neutropenic patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Features of invasive staphylococcal disease in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Lysostaphin: Use of a Recombinant Bactericidal Enzyme as a Mastitis Therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Lysostaphin Disrupts Staphylococcus aureus and Staphylococcus epidermidis Biofilms on Artificial Surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

Combinations of lysostaphin with beta-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181994A53

10.1203/PDR.0B013E3181994A53

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

Dimensions Publication ID

1046420777

0 references

1 reference

20 December 2017